The prostaglandin PGE 2 , a metabolite of the cyclooxygenase pathway, activates Ca 2+ -permeable cation channels in erythrocyte cell membranes leading to entry of Ca 2+ with subsequent eryptosis, i.e. cell shrinkage, breakdown of phosphatidylserine (PS) asymmetry and membrane blebbing, all features typical for apoptosis in nucleated cells. PS exposing cells are recognized by macrophages, engulfed, degraded and thus cleared from circulating blood. The present study explored whether the specific lipoxygenase inhibitor Bay-Y5884 influences eryptosis. As determined by competitive ELISA, Bay-Y5884 (20 µM) enhanced the release of PGE 2 from human erythrocytes. According to whole-cell patch-clamp, Bay-Y5884 (20 µM) activated nonselective cation channels. The effect of Bay-Y5884 on cation channels was abolished by the cyclooxygenase inhibitor diclophenac (10 µM). Bay-Y5884 (30-40 µM) significantly increased erythrocyte free Ca 2+ concentration and PS exposure as analyzed in flow cytometry by Fluo3 fluorescence and annexin-V binding, respectively. PS exposure triggered by 20 µM (but not by 40 µM) Bay-Y5884 was blunted by cyclooxygenase inhibitors acetylsalicylic acid (50 µM) and diclophenac (10 µM). In conclusion, the lipoxygenase inhibitor Bay-Y5884 enhances erythrocyte PGE 2 formation with subsequent activation of non-selective cation channels, Ca 2+ entry and phospholipid scrambling.
Introduction
Erythrocytes have earlier been considered unable to undergo apoptosis, as they lack mitochondria and nuclei, key organelles in the apoptotic machinery of nucleated cells [1] . However, treatment of erythrocytes with the Ca 2+ -ionophore ionomycin has been shown to trigger membrane blebbing and break down of phosphatidylserine asymmetry of the cell membrane [2] [3] [4] [5] , typical features of apoptosis in other cell types [1, 6] . The breakdown of phosphatidylserine asymmetry results from scrambling of 234 the cell membrane, which is stimulated by increase of cytosolic Ca 2+ activity [7, 8] . As macrophages are equipped with receptors specific for phosphatidylserine [9] [10] [11] , erythrocytes exposing phosphatidylserine at their surface will be rapidly recognized, engulfed and degraded [12, 13] . Thus [14, 15] , fostering cell shrinkage [16] , another typical feature of apoptotic cells [Lang et al. 1998 ]. The similarity of suicidal erythrocyte death to the apoptosis of nucleated cells prompted the term eryptosis for the description of this particular erythrocyte death [17] . The molecular mechanisms of eryptosis are similar but not necessarily identical to those leading to erythrocyte senescence [17] [18] [19] [20] [21] or neocytolysis [20] .
Stimulators of Ca 2+ entry include hyperosmotic shock by increase of extracellular osmolarity, oxidative stress by addition of t-butylhydroxyperoxide (t-BHP) and energy depletion by removal of extracellular glucose [5] , which all activate Ca 2+ permeable cation channels [22, 23] . Most recent observations revealed that those channels are activated by PGE 2 [24] . The effects of hyperosmotic shock and removal of extracellular Cl -on cation channel activity and phosphatidylserine exposure were paralleled by release of PGE 2 , mimicked by exogenous addition of PGE 2 and blunted in the presence of cyclooxygenase inhibitors [24] . It was thus concluded that formation of PGE 2 and subsequent activation of cation channels contributed to the stimulation of erythrocyte "apoptosis" following hyperosmotic shock and Cl -removal.
The present experiments have been performed to explore whether other eicosanoid signaling pathways are involved in the regulation of eryptosis. As evidence for lipoxygenase activity in erythrocytes has been obtained previously [25] [26] [27] [28] , the effect of the specific lipoxygenase inhibitor Bay-Y5884 has been explored. It is shown that Bay-Y5884 enhances erythrocyte PGE 2 release, activates cation channels, leads to Ca 2+ entry and triggers erythrocyte phosphatidylserine exposure.
Materials and Methods

Solutions
Erythrocytes were drawn from healthy volunteers and used either without purification or after separation by centrifugation for 25 min; 2000 g over Ficoll (Biochrom KG, Berlin, Germany). Experiments were performed at 37°C in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)/ NaOH, 5 glucose, 1 CaCl 2 ; pH 7.4. For chloride-free conditions, a 0 Cl -bath solution was used containing 125 Na-gluconate, 32 HEPES/NaOH (pH 7.4), 5 glucose, 1 Ca(gluconate) 2 , and 1 MgSO 4 . Where indicated, lipoxygenase inhibitor Bay-Y5884 (20-40 µM), cycloxygenase inhibitors acetylsalicylic acid (50 µM) or diclophenac (10 µM), were added. The substances were dissolved in final concentrations of 0.1 % dimethyl sulfoxide (DMSO) (Bay-Y5884, ionomycin and diclophenac), or in water (acetylsalicylic acid). Acetylsalicylic acid, diclophenac and ionomycin were purchased from Sigma (Taufkirchen, Germany), Bay-Y5884 was from BAYER (Leverkusen, Germany).
Determination of PGE 2
One billion erythrocytes were treated with 0.9 ml NaCl Ringer solution (control) with or without addition of Bay-Y5884 (20 µM). After incubation, cells were pelleted by centrifugation at 4 °C, 450 x g for 5 min. The supernatant was removed and stored at -20°C. The cells were lysed by addition of 0.4 ml 10 mM HEPES (pH 7.4). The lysate was cleared by centrifugation at 4°C, 22000 g for 10 min and likewise stored at -20°C. PGE 2 concentrations in the supernatant and in the lysate were determined using the Correlate-EIA TM Prostaglandin E 2 Enzyme Immunoassay Kit from Assay Designs, Inc. (Ann Arbor, MI, USA) according to the manufacturer's instructions. Briefly, the samples were diluted 1:2.5 with assay buffer. Then, 100 µl sample, 50 µl alkaline phosphatase PGE 2 conjugate and 50 µl monoclonal anti-PGE 2 EIA antibody were applied to goat anti-mouse IgG microtiter plates and incubated at room temperature for 2 h. After washing, 200 µl p-nitrophenyl phosphate substrate solution was added and incubated at room temperature for 45 min. Finally, the optical density at 405 nm was measured in a microplate reader. PGE 2 concentrations in the samples were calculated from a PGE 2 standard curve (39.1 -5000 pg/ml) which was run in parallel. PGE 2 levels in the supernatant of control erythrocytes were 106 ± 5 pg per 10 9 cells, and were set as 100 %. PGE 2 levels in the samples of erythrocytes exposed to Bay-Y5884 were calculated as % of the appropriate controls.
Patch clamp
Patch clamp experiments have been performed at room temperature in voltage-clamp, fast-whole-cell mode according to Hamill et al. [29] . The cells were continuously superfused through a flow system inserted into the dish. The bath was grounded via a bridge filled with NaCl Ringer solution (see above). Borosilicate glass pipettes (8-12 MOhm tip resistance; GC 150 TF-10, Clark Medical Instruments, Pangbourne, UK) manufactured by a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany) were used in combination with a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, Germany). The currents were recorded by an EPC-9 amplifier (Heka, Lambrecht, Germany) using Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, N.Y., USA). Wholecell currents were determined at ten successive 700-ms square pulses from the -20 mV holding potential to potentials between -100 mV and +80 mV. The current values were 3 kHz low-pass filtered.
The pipette solution contained (in mM): 115 Na-gluconate, 10 NaCl, 1 MgATP, 1 EGTA, and 5 HEPES/NaOH (pH 7.4) and Eryptosis Upon Lipoxygenase Inhibition -free (Na-gluconate, closed symbols) bath solutions in the absence (closed circles) or in the presence of Bay-Y5884 (20 µM, closed triangles). C. Mean whole-cell conductance (± SEM; n = 6, each) as recorded in (B) with NaCl, Nagluconate, Na-gluconate/Bay-Y5884 and Na-gluconate/Bay-Y5884/diclophenac in the bath. Data were calculated from (B) by linear regression. * indicates significant difference (p<0.05; ANOVA). The offset potentials between both electrodes were zeroed before sealing. The potentials were corrected for liquid junction potentials as estimated according to Barry & Lynch [30] . The original whole-cell current traces are depicted without filtering (acquisition frequency of 5 kHz) and currents of the individual voltage square pulses are superimposed. The applied voltages refer to the cytoplasmic face of the membrane with respect to the extracellular space. The inward currents, defined as flow of positive charge from the extracellular to the cytoplasmic membrane face, are negative currents and depicted as downward deflections of the original current traces.
FACS analysis
FACS analysis was performed essentially as described [31] . After incubation, cells were washed in annexin-binding buffer containing (in mM) 125 NaCl, 10 HEPES; (pH 7.4) and 5 CaCl 2 . Erythrocytes were stained with Annexin-Fluos (Roche Diagnostics, Mannheim, Germany) at a 1:100 dilution. After 15 min, samples were diluted 1:5 and measured by flow cytometric analysis (FACS-Calibur from Becton Dickinson, Heidelberg, Germany). Cells were analysed by forward and sideward scatter and annexin-fluorescence intensity was measured in FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
Measurement of intracellular Ca
2+
Intracellular Ca 2+ measurements were performed as described [32] . Briefly, erythrocytes were loaded with Fluo-3/AM (Calbiochem; Bad Soden, Germany) by addition of 10 µl of a Fluo-3/AM stock solution (2.0 mM in DMSO) to 10 ml erythrocyte suspension (0.16 % hematocrit in Ringer). The cells were incubated at 37°C for 15 min under vigorous shaking and protection from light. An additional 10 µl of Fluo-3/AM was added, with incubation carried out for 25 min. Fluo-3-AM-loaded erythrocytes were centrifuged at 1000 g for 3 min at 22 °C and washed two times with Ringer solution containing 0.5 % bovine serum albumin (Sigma) and once with Ringer. For flow cytometry, Fluo-3/AM-loaded erythrocytes were resuspended in 5 ml Ringer (0.32 % hematocrit) containing Bay-Y5884 (20 -40 µM), the Ca 2+ ionophore ionomycin (1 µM; Sigma; Taufkirchen, Germany) or vehicle alone and incubated for different time periods at 37°C. Then, Ca 2+ -dependent fluorescence intensity was measured in fluorescence channel FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
Statistics
Data were expressed as means ± SEM and statistical analysis was made by ANOVA or unpaired two-tailed t-test, as appropriate, p < 0.05 was considered statistically significant. 
Results
As determined by competitive ELISA, a specific lipoxygenase inhibitor Bay-Y5884 (20 µM) enhanced the release of prostaglandin PGE 2 (Fig. 1) .
The formation of PGE 2 is expected to activate cation channels in the cell membrane [24] . Patch clamp experiments have thus been performed to explore the effect of the lipoxygenase inhibitor on the erythrocyte cation channel activity. The membrane conductance of human erythrocytes in NaCl Ringer solution was low, amounting to about 78 pS. Application of Na-gluconate bath solution resulted in an increase of the cation conductance, an effect which was indeed significantly enhanced by the lipoxygenase inhibitor Bay-Y5884 (20 µM, Fig. 2 ). The effect of Bay-Y5884 on cation channel activity was abolished by the cyclooxygenase inhibitor diclophenac (10µM, Fig. 2A,C) .
Activation of the cation channels should stimulate Ca 2+ entry and thus increase cytosolic Ca 2+ activity [5, 22, 23] . Thus, Fluo3 fluorescence was employed to test for an effect of the lipoxygenase inhibitor Bay-Y5884 on the erythrocyte cytosolic Ca 2+ activity. As illustrated in Fig. 3 , Bay-Y5884 (40 µM) indeed increased the Fluo3 fluorescence.
An increase of cytosolic Ca 2+ activity has previously been shown to trigger cell membrane scrambling leading to phosphatidylserine exposure at the cell surface [2] [3] [4] [5] . The percentage of phosphatidylserine exposing erythrocytes has thus been determined. Annexin binding in flow cytometry was taken as a measure of phosphatidylserine exposure. As illustrated in Fig. 4A -C, Bay-Y5884 (20 µM) significantly enhanced the percentage of annexin binding erythrocytes (13±1 %, n=36) . The effect of Bay-Y5884 (20 µM) on annexin binding was significantly blunted by acetylsalicylic acid (50 µM, Fig. 4A, C) or diclofenac (10 µM, Fig. 4A, C) . A higher concentration of Bay-Y5884 (40 µM) dramatically enhanced the percentage of annexin binding erythrocytes (32±4 %, n=18, Fig. 4B and 4D) . However, at this Bay-Y5884 concentration acetylsalicylic acid (50 µM) could not block the effect of Bay-Y5884 (Fig. 4D) .
Entry of Ca
2+
is further expected to activate Ca 2+ sensitive K + channels and subsequent cell shrinkage [16] , which should be apparent from a decrease of forward scatter in flow cytometry. As illustrated in Fig. 5 , Bay-Y5884 (30 µM) tended to decrease the forward scatter of erythrocytes, an effect, however, not reaching statistical significance.
Discussion
The present observations demonstrate that a specific lipoxygenase inhibitor Bay-Y5884 increases the formation of prostaglandin E 2 (PGE 2 ), activates unselective cation channels, increases cytosolic Ca serine exposure. PGE 2 has previously been shown to trigger eryptosis at least in part by activating the cation channels and thus increasing cytosolic Ca 2+ activity [24] . Furthermore, PGE 2 has been shown to be generated by mechanically stressed adult human red blood cells [33] and to activate nonselective cation channels [34] .
For the triggering of eryptosis, however, concentrations of PGE 2 are required, which are presumably encountered only in pathophysiological conditions [34] . Clearly, inhibition of lipoxygenase does not generate a physiological condition. Accordingly, Bay-Y5884 may have additional effects not related to lipoxygenase inhibition. As a matter of fact, the incomplete efficacy of cycloxygenase inhibition suggests that the substance may be effective through additional mechanisms, which may or may not be related to eicosanoid metabolism. Moreover, inhibition of cyclooxygenase blunts only the effect of 20 µM but not of 40 µM Bay-Y5884.
The phosphatidylserine exposure following treatment of the erythrocytes with Bay-Y5884 is at least partially secondary to Ca 2+ sensitive cell membrane scrambling [2, 3] . Increased cytosolic Ca 2+ is a main trigger for eryptosis. Known triggers of nucleated cell apoptosis, such as serum deprivation and staurosporine, do not affect survival of mature erythrocytes [4] . Ca 2+ erythrocytes enters through amiloride sensitive, cell volume regulated cation channels which have been characterized earlier [5, 22, 23, 35] .
Besides its influence on cell membrane scrambling, Ca 2+ entry activates the Ca 2+ sensitive K + channel in the erythrocyte cell membrane, which leads to hyperpolarization of the cell membrane and subsequent erythrocyte loss of KCl [14, 15, 36] , which is supported by the activity of Cl -channels [37] . PGE 2 has indeed been shown to trigger the release of K + from erythrocytes [38] . The following cellular release of K + and Cl -together with osmotically obliged water then leads to cell shrinkage [38] . Similar to what has been shown for nucleated cell apoptosis [39] [40] [41] [42] [43] [44] [45] , cellular loss of K + participates in the triggering of eryptosis [16] .
The present observations may be relevant for the survival of erythrocytes. Phosphatidylserine exposing erythrocytes are prone to be taken up by macrophages. [12, 46] and are thus cleared from circulating blood [4] . Phosphatidylserine exposure may be also involved in erythrocyte ageing, which is likewise paralleled by an increase of the cytosolic Ca 2+ activity [46, 47] . Moreover, Ca 2+ entry and subsequent phosphatidylserine exposure may result from oxidative stress or defects of antioxidative defence [48] and may contribute to the premature death of erythrocytes in certain erythrocyte disorders [49] , such as sickle cell disease [50, 51] , thalassemia [52] or iron deficiency [53, 54] .
Eryptosis may further compromise microcirculation and erythrocytes may participate in the regulation of hemostasis [55] [56] [57] [58] .
Eryptosis may not only be influenced by eicosanoids generated in the erythrocytes themselves, but as well by lipid mediators released from other blood cells, from cells of the vascular wall or from extravascular tissue. For instance, PGE 2 could be released from platelets [38] or from renal tissue during acute renal failure, which is paralleled by trapping of erythrocytes in renal medulla [59, 60] .
Eicosanoids and eicosanoid dependent regulation of cation channels and Ca 2+ entry may not only affect eryptosis, but be similarly important for the regulation of nucleated cell survival. For instance, PGE 2 has been demonstrated to either stimulate [61] or inhibit [62] [63] [64] [65] [66] [67] [68] apoptosis of nucleated cells. The lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA) has been shown to stimulate apoptosis of monocytic carcinosarcoma cells [69, 70] , lymphocytic cells [71, 72] , breast cancer cells [73] and pancreatic cancer cells [74] , but to inhibit CD95 induced death of glioma cells [75] and cationic liposomeinduced apoptosis of macrophages [76] . In none of those studies, however, the effect of lipoxygenase inhibitors on cation channel activity has been explored.
